The End Fund receive grant from Astellas Global Health Foundation

The Astellas Global Health Foundation announced its first grant since the Foundation’s inception, awarding $750,000 to the END Fund.

The END Fund will use the investment to deliver NTD treatments through mass drug administration mechanisms designed to control and eliminate NTDs in the Democratic Republic of Congo, one of the world’s poorest countries ranking among the highest in NTD prevalence.

Find out More Here.